Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Pediatric multiple sclerosis.
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
CNS myelin structural modification induced in vitro by phospholipases A2.
Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Demyelinating diseases in Asia.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.

Pages